Barclays Downgrades Xylem to Equalweight
Barclays downgraded Xylem Inc. from Overweight to Equalweight, setting a new price target of $104.
Stocks · News reference
Xylem Director Christian Koch Purchases Shares Worth Approximately $985,000
Xylem Inc. director Christian Koch acquired 11,000 shares of the company's common stock in a recent open-market transaction.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
UBS Maintains Neutral on Xylem, Lowers Price Target to $99
This Lennox International Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Analysts downgraded Renasant, Lennox, Peapack-Gladstone, Alkami and Xylem; price targets for RNST and XYL were cut.